Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Centre Hospitalier Universitaire Sainte-Justine | UNKNOWN |
| University of Alberta/Stollery Children's Hospital | UNKNOWN |
Not provided
Not provided
Not provided
The iPeer2Peer (iP2P) program is an online peer support mentorship program that provides modelling and reinforcement by trained young adult peer mentors to adolescent mentees with the same condition. A quasi-experimental single-arm pre-post study design will be employed across three sites. We will recruit 40 mentees (12-17 years of age) and 12-15 mentors (18-30 years of age) who will undergo training in mentoring and the use of eHealth technology. Mentor-mentee pairings will connect over 15 weeks through video calls and text messaging to provide peer support and encourage disease self-management skills. Data will be collected using standardized instruments and interviews across three time points.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| iPeer2Peer Program | Experimental | Participates in the iPeer2Peer program |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| iPeer2Peer Program | Behavioral | Behavioral: iPeer2Peer Support Mentorship Program is an online peer support mentorship program that has been established in multiple chronic disease populations as a self-management intervention, including chronic pain and juvenile idiopathic arthritis. The iPeer2Peer program provides modeling and reinforcement by pre-screened and trained young adult peer mentors to adolescent mentees. |
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability (Mentees) | Whether the innovation is agreeable, palatable or satisfactory | 15 weeks after baseline/immediately after the intervention |
| Acceptability (Mentors) | Whether the innovation is agreeable, palatable or satisfactory | Study completion, an average of 1 year |
| Adoption (Mentees) | The intention, initial decision or action to try or use an innovation | Baseline to 12 weeks post-program completion |
| Adoption (Mentors) | The intention, initial decision or action to try or use an innovation | Baseline to study completion, an average of 1 year |
| Feasibility (Mentees) | The extent to which an innovation can be used or carried out successfully in a given setting | Baseline to 12 weeks post-program completion |
| Feasibility (Mentors) | The extent to which an innovation can be used or carried out successfully in a given setting | Baseline to study completion, an average of 1 year |
| Appropriateness (Mentees) | The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem | Baseline to 12 weeks post-program completion |
| Measure | Description | Time Frame |
|---|---|---|
| Disease self-management skills (Mentees) | Baseline to 12 weeks post-program completion | |
| Adherence (Mentees) | Clinic attendance, completion of scheduled tests and procedures, and adolescent medication barriers scale |
Not provided
Mentee inclusion criteria:
Mentor inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Samantha J Anthony, PhD | Contact | 416-813-7654 | 303126 | samantha.anthony@sickkids.ca |
| Sophie Bui, BHSc | Contact | sophie.bui@sickkids.ca |
| Name | Affiliation | Role |
|---|---|---|
| Samantha J Anthony, PhD | The Hospital for Sick Children | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Hospital for Sick Children | Recruiting | Toronto | Ontario | M5G 1X8 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D009202 | Cardiomyopathies |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Quasi-experimental single arm pre-post study
Not provided
Not provided
Not provided
Not provided
|
| Appropriateness (Mentors) | The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem | Baseline to study completion, an average of 1 year |
| Level of engagement (Mentees) | 15 weeks after baseline/immediately after the intervention |
| Level of engagement (Mentors) | Study completion, an average of 1 year |
| Baseline to 12 weeks post-program completion |
| Quality of life (Mentees) | Baseline to 12 weeks post-program completion |
| Perceived social support (Mentees) | Baseline to 12 weeks post-program completion |
| Emotional distress (Mentees) | Baseline to 12 weeks post-program completion |
| Resiliency (Mentees) | Baseline to 12 weeks post-program completion |
| Assessment of mentor quality (Mentees) | 15 weeks after baseline/immediately after the intervention |
| Physical and emotional symptoms (Mentors) | Baseline to study completion, an average of 1 year |
| Perceived social role satisfaction (Mentors) | Baseline to study completion, an average of 1 year |
| Self-efficacy (Mentors) | Baseline to study completion, an average of 1 year |